Connect with us

Tampa pharma firm advances equity offering

March 21, 2019 - Oragenics Inc. expects to receive $12.5 million in gross proceeds in a new equity offering. The company will sell stock and warrants to buy stock at 75 cents a share. Oragenics (NYSE American: OGEN), based in Tampa, is developing antibiotics and treatments for oral mucositis.

More Zaps Frontpage

The St. Pete Catalyst

The Catalyst honors its name by aggregating & curating the sparks that propel the St Pete engine.  It is a modern news platform, powered by community sourced content and augmented with directed coverage.  Bring your news, your perspective and your spark to the St Pete Catalyst and take your seat at the table.

Email us: spark@stpetecatalyst.com

Subscribe for Free

Share with friend

Please enter email address you want to share this article with